Author - Ziad

XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery

New York-based Xylyx Bio, a leader in advanced disease models, today announced the release of normal and fibrotic NativeCoat™ human lung- and liver-specific ECM substrates for antifibrotic drug discovery to increase predictiveness of high throughput screening and improve evaluation of efficacy of biopharmaceutical drug candidates for hard to treat fibrotic diseases such as IPF and NASH. Read more >>

Myomo® Extends and Strengthens its Global MyoPro™ Patent Portfolio

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced additional intellectual property protection with the issuance of new patents in the U.S. and Europe related to MyoPro™, its unique wearable robotic brace for arm and hand paralysis. Read more >>

Framingham’s Rising Star

At 15, highschooler David Zamarin sold his cleaning company to invest in a new product idea leading to the founding of Framingham-based DetraPel (in comparison, at age 13, Bose Corporation’s Amar Bose began repairing radio sets for pocket money for repair shops in Philadelphia.) DetraPel manufactures non-toxic fabric protectors that are gaining world-wide acclaim. Read more >>”

Grapefruit USA, Inc. Commences Production of Its Patented Disruptive Time Release Hourglass(TM) THC+CBD Delivery Cream

Grapefruit USA, Inc., a fully licensed California based cannabis company, is announcing today that it has commenced production of the Hourglass™ time release THC+CBD delivery cream at its manufacturing facility in the Coachillin Canna-Business Park in Desert Hot Springs, California, pursuant to its Exclusive License and Supply Agreement with Zylö Therapeutics Inc. Read more >>